Balyasny Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2164 |
|
|
2024
Q3 | – | Sell |
-59,810
| Closed | -$11M | – | 2175 |
|
|
2024
Q2 | $11M | Sell |
59,810
-64,393
| -52% | -$11.8M | 0.02% | 612 |
|
|
2024
Q1 | $22.1M | Sell |
124,203
-132,401
| -52% | -$23.6M | 0.04% | 430 |
|
|
2023
Q4 | $31.8M | Buy |
256,604
+223,962
| +686% | +$27.8M | 0.06% | 316 |
|
|
2023
Q3 | $3.79M | Sell |
32,642
-3,948
| -11% | -$458K | 0.01% | 855 |
|
|
2023
Q2 | $4.3M | Sell |
36,590
-4,545
| -11% | -$534K | 0.01% | 816 |
|
|
2023
Q1 | $3.29M | Buy |
41,135
+32,759
| +391% | +$2.62M | 0.01% | 929 |
|
|
2022
Q4 | $664K | Buy |
+8,376
| New | +$664K | ﹤0.01% | 1373 |
|